Author:
Putman Melissa S.,Gordon Catherine M.
Reference174 articles.
1. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev. 1998;78(4):1193–231.
2. Accurso FJ, Rowe SM, Clancy JP, Boyle MP, Dunitz JM, Durie PR, et al. Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation. N Engl J Med. 2010;363(21):1991–2003.
3. Matkovic V, Jelic T, Wardlaw GM, Ilich JZ, Goel PK, Wright JK, et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional model. J Clin Invest. 1994;93(2):799–808.
4. Heaney RP, Abrams S, Dawson-Hughes B, Looker A, Marcus R, Matkovic V, et al. Peak bone mass. Osteoporos Int. 2000;11(12):985–1009.
5. Bringhurst FR, Demay MB, Kronenberg HM. Hormones and disorders of mineral metabolism (Chapter 28). In: Wilson ID, Foster DW, Kronenberg HM, Larsen PR, editors. Williams textbook of endocrinology. 12th ed. Philadelphia, PA: Elsevier; 2011.